Sharma, Jyoti
Du, Ming
Wong, Eric
Mutyam, Venkateshwar
Li, Yao
Chen, Jianguo
Wangen, Jamie http://orcid.org/0000-0001-7008-5749
Thrasher, Kari
Fu, Lianwu
Peng, Ning
Tang, Liping
Liu, Kaimao
Mathew, Bini
Bostwick, Robert J.
Augelli-Szafran, Corinne E.
Bihler, Hermann http://orcid.org/0000-0002-8167-1548
Liang, Feng
Mahiou, Jerome
Saltz, Josef
Rab, Andras
Hong, Jeong
Sorscher, Eric J.
Mendenhall, Eric M. http://orcid.org/0000-0002-7395-6295
Coppola, Candice J.
Keeling, Kim M. http://orcid.org/0000-0003-0471-5858
Green, Rachel http://orcid.org/0000-0001-9337-2003
Mense, Martin http://orcid.org/0000-0003-0280-9789
Suto, Mark J.
Rowe, Steven M. http://orcid.org/0000-0001-9045-0133
Bedwell, David M. http://orcid.org/0000-0002-6605-818X
Article History
Received: 1 April 2020
Accepted: 22 June 2021
First Online: 16 July 2021
Competing interests
: This work was supported by funding from NIH and the CF Foundation. M.M., E.W., F.L., and H.B. are the employees of the Cystic Fibrosis Foundation. D.M.B. is a paid consultant for PTC Therapeutics, Inc. and Zikani Therapeutics, Inc. S.M.R. reports grants from PTC Therapeutics, grants, personal fees and non-financial support from Vertex Pharmaceuticals Incorporated, grants, personal fees and non-financial support from Novartis, grants from Eloxx, and grants from Galapagos/Abbvie during the conduct of the study. Grants from Bayer, grants from Forest Research Institute, grants from AstraZeneca, grants from N30/Nivalis, grants from Galapagos/AbbVie, grants from Proteostasis, grants and personal fees from Celtaxsys, personal fees from Bayer, personal fees from Renovion, grants and personal fees from Synden/Synspira, personal fees from Genentech, personal fees and non-financial support from Boeringher Ingelheim, grants from Jannssen, Vivus, Actelion, Johnson and Johnson, and other related entities are outside the submitted work. All other authors declare no competing interests.